352Based on these observations, the hemodynamics team initiated the treatment of myocardial infarction with injection of bone marrow stem cells in a retrograde way through the coronary sinus. Case ReportThe patient is a 63-year-old, obese man with diabetes, hypertension, dyslipemia, and a positive familial history of coronary artery disease and previous myocardial infarction in the inferior wall 4 years earlier. Twelve days previously, the patient had an acute myocardial infarction in the anterior wall, which evolved for 14 hours. The patient underwent angioplasty and successful stent implantation but began to complain of fatigue on mild effort and nocturnal paroxysmal dyspnea.The electrocardiogram showed third-degree left bundle-branch block. The echocardiogram showed cavitary enlargement, anterior and inferior akinesia, and an ejection fraction of 24%. Thallium-201 myocardial scintigraphy showed anterior and inferior fibrosis. The cardiac catheterization evidenced a significantly enlarged ventricle due to anterior and inferior akinesis, and apical dyskinesis. On angiography, the ejection fraction was 25%, and the left ventricular Pd2 was 34 mmHg. The right coronary artery showed a diffuse lesion in its proximal segment and distal occlusion. The left main coronary artery had no obstruction, the circumflex artery had parietal irregularities and occluded marginal branches, and was opacified through the homocollaterals. The anterior descending artery was diffusely damaged from the junction of the middle and distal segments onwards. The first medium-caliber diagonal branch had a severe lesion in its origin.Taking all this into consideration, the patient and his family were presented with the possibility of retrograde bone-marrow stem cell injection through the anterior descending vein to cause myogenesis and angiogenesis. The patient agreed with the procedure proposed, as did the committee on ethics subordinate to the Argentinean government and Health Ministry.With the patient under general anesthesia, puncture of the iliac crest and bone marrow aspiration were performed.The upper layer (leukocyte concentrate containing mononuclear cells) was separated from the erythrocytes by centrifugation, and the latter were reinfused into the patient. Then the leukocytic Adult stem cells removed from the bone marrow have been used for the treatment of ischemia and acute myocardial infarction, improving ventricular function and/or myocardial perfusion and/or reducing the size of the infarction 1-4 . We present a new technique for retrograde stem cell infusion in the coronary sinus for the treatment of acute myocardial infarction used for the first time in human beings.Stem cells have been infused according to the 2 following routes: 1) anterograde intracoronary infusion, about which Giordano 5 reported that the endothelium of the coronary microcirculation is continuous, constituting a barrier to the passage of macromolecules to the myocardium; that author also reported that another area of possible resistance is the vascular se...
Resumo Hemangioma é um tumor frequente, geralmente diagnosticado em crianças, constituindo quase 10% das neoplasias benignas. Um hemangioma com crescimento na parede de um vaso é extremamente raro, e deve ser diferenciado de outras malformações vasculares de mesma origem. Apresentamos um caso raro de hemangioma de veia jugular externa e discutimos sua propedêutica e manejo.
Background: In-stent restenosis due to myointimal hyperplasia after angioplasty is common and limits long-term patency. Treatments using balloons coated with antiproliferative drugs may offer an alternative option for this pathology. Objectives: To demonstrate the efficacy and complications (death, major amputations, etc.) of drug-coated balloons for treatment of in-stent restenosis in femoropopliteal segments. Methods: This was a retrospective cohort study of 32 consecutive patients treated between 2012 and 2016 who underwent treatment to correct in-stent restenosis in the femoropopliteal segment using paclitaxel-coated balloons. The success rate was measured in terms of technical success and restenosis of less than 50% on Doppler ultrasonography at 30, 90, and 180 days after the procedure. Results: Four patients (12.5%) exhibited restenosis greater than 50%, one (3.1%) after 90 days and three (9.4%) after 180 days, equating to a success rate of 87.5% of procedures, and by 180 days all patients experienced improvement or cessation of the signs and/or symptoms they had presented prior to the procedure. There were no deaths and complications occurred in just 2 cases in the immediate postoperative period. Conclusions: Short-term results are promising, with reductions in the magnitude of restenosis and a low rate of complications. Further studies are needed that can demonstrate the long-term effects and the economic impacts in comparison to other procedures.
Resumo A doença cística adventicial da artéria poplítea é uma doença pouco frequente, que deve ser considerada no diagnóstico diferencial de pacientes jovens com claudicação intermitente e sem fatores de risco para doença arterial periférica aterosclerótica. Apresentamos um caso de claudicação intermitente de membros inferiores em paciente masculino de 51 anos no qual essa doença foi diagnosticada. Foi submetido a ressecção do segmento de artéria comprometido e interposição de safena autóloga ipsilateral. Discutimos alternativas diagnósticas e terapêuticas.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.